{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:15:10Z","timestamp":1769879710801,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":5632,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1111\/j.1600-6143.2007.01860.x","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T04:13:51Z","timestamp":1181362431000},"page":"1832-1841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy of Anti-IL-2 Receptor Antibodies Compared to no Induction and to Antilymphocyte Antibodies in Renal Transplantation"],"prefix":"10.1016","volume":"7","author":[{"given":"V.","family":"Patlolla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.W.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Mandelbrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2007.01860.x_bib1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib2","doi-asserted-by":"crossref","unstructured":"Vincenti F, Kirkman R, Light S et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 1998; 338: 161\u2013165.","DOI":"10.1056\/NEJM199801153380304"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib3","doi-asserted-by":"crossref","unstructured":"Kahan BD, Rajagopalan PR, Hall M. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation 1999; 67: 276\u2013284.","DOI":"10.1097\/00007890-199901270-00016"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib4","doi-asserted-by":"crossref","unstructured":"Nashan B, Light S, Hardie IR, Lin A, Johnson JR. Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group. Transplantation 1999; 67: 110\u2013115.","DOI":"10.1097\/00007890-199901150-00019"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00007890-200110150-00014","article-title":"A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients.","volume":"72","author":"Ponticelli","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00007890-200301150-00007","article-title":"Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation.","volume":"75","author":"Lawen","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib7","first-page":"393","article-title":"Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: A three-year prospective randomized trial.","volume":"16","author":"Sheashaa","year":"2003","journal-title":"J Nephrol"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1034\/j.1600-6143.2002.20612.x","article-title":"Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation.","volume":"2","author":"Ahsan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib9","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/S0041-1345(01)02366-1","article-title":"Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab.","volume":"33","author":"Folkmane","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonists for renal transplant recipients: A meta-analysis of randomized trials.","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/bmj.326.7393.789","article-title":"Interleukin-2 receptor monoclonal antibodies in renal transplantation: Meta-analysis of randomised trials.","volume":"326","author":"Adu","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib12","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.TP.0000100826.58738.2B","article-title":"Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.","volume":"76","author":"Cherikh","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib13","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/00007890-200112270-00008","article-title":"Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.","volume":"72","author":"Sollinger","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.TP.0000129812.68794.CC","article-title":"Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids.","volume":"78","author":"Mourad","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-6143.2002.020109.x","article-title":"Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.","volume":"2","author":"Lebranchu","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib16","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJM199004263221702","article-title":"Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.","volume":"322","author":"Soulillou","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.TP.0000153506.07816.F0","article-title":"Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients.","volume":"79","author":"Haririan","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib18","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/S0041-1345(02)03487-5","article-title":"Bolus anti-thymocyte globulin induction in renal transplant recipients: A comparison with conventional ATG or anti-interleukin-2 receptor antibody induction.","volume":"34","author":"Nampoory","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib19","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0041-1345(03)00679-1","article-title":"ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: One-year results.","volume":"35","author":"Tullius","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib20","doi-asserted-by":"crossref","unstructured":"Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D, Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355: 1967\u20131977.","DOI":"10.1056\/NEJMoa060068"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/01.TP.0000134399.10352.E4","article-title":"The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function.","volume":"78","author":"Knight","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib22","unstructured":"U.S. Department of Health and Human Services. 2005 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1995\u20132004. Rockville, MD: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation."},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib23","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.4049\/jimmunol.169.7.3744","article-title":"Physiological mechanisms of regulating alloimmunity: Cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size.","volume":"169","author":"Sho","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib24","first-page":"438","article-title":"Thymoglobulin versus simulect for induction immunosuppression in cadaveric renal transplant recipients: Expanded results from a prospective, randomized, multicenter trial.","volume":"3","author":"Brennan","year":"2003","journal-title":"American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib25","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1600-6143.2004.00624.x","article-title":"Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival.","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.0105-2896.2006.00414.x","article-title":"Regulatory T cells in the periphery.","volume":"212","author":"Lohr","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.it.2006.01.005","article-title":"The dichotomous role of IL-2: Tolerance versus immunity.","volume":"27","author":"Fehervari","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1600-6143.2007.01860.x_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: A collaborative transplant study report.","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2007.01860.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522028040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522028040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2007.01860.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:41:06Z","timestamp":1761626466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522028040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1600613522028040"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01860.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Anti-IL-2 Receptor Antibodies Compared to no Induction and to Antilymphocyte Antibodies in Renal Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01860.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}